Obesity predisposes patients to several debilitating metabolic diseases, cardiovascular disorders, liver diseases, and cancers. Research into the mechanisms underlying obesity and its comorbid conditions presents an opportunity to make a significant impact on human health.Are you making the most use of obese animal models in your preclinical research?
Join Taconic Biosciences for this free webinar on the application of diet-induced obese animal models used for studying human obesity and its associated pathologies.
Michael R. Briggs, PhD
Michael Briggs is the CSO of Woodland Biosciences. He has developed a deep interest in oncology medicine and is exploring discovery research into the connections between obesity, diabetes, liver disease, and fast-growing cancers such as hepatocellular carcinoma and pancreatic cancer.
Nikole Siegmund, BS, LAT
Director of Laboratory Operations
Nikole Siegmund is the director of laboratory operations at Woodland Biosciences and a former Team Leader for research at Charles River Laboratories. Her team represents decades of combined CRO and pharmaceutical company experience.
© 2021 Taconic Biosciences, Inc. All rights reserved.